METASTATIC RENAL CELL CARCINOMA (MRCC)
Clinical trials for METASTATIC RENAL CELL CARCINOMA (MRCC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC RENAL CELL CARCINOMA (MRCC) trials appear
Sign up with your email to follow new studies for METASTATIC RENAL CELL CARCINOMA (MRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a scan let kidney cancer patients pause treatment?
Disease control Recruiting nowThis study tests whether PET/CT scans can safely guide a treatment break for people with advanced kidney cancer. Participants must have responded well to at least 12 months of standard therapy. The goal is to see if stopping treatment based on scan results can maintain disease co…
Matched conditions: METASTATIC RENAL CELL CARCINOMA (MRCC)
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 17, 2026 05:33 UTC
-
New hope for advanced kidney cancer: experimental drug trial launches
Disease control Recruiting nowThis study tests a new medicine, PF-08634404, for adults with advanced kidney cancer that has spread. The goal is to see if the drug, given alone or with other cancer treatments, can shrink tumors and is safe. Participants must not have had prior treatment for their advanced canc…
Matched conditions: METASTATIC RENAL CELL CARCINOMA (MRCC)
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 15, 2026 12:00 UTC
-
New hope for kidney cancer: Triple-Drug combo trial launches
Disease control Recruiting nowThis study tests three different drug combinations in 120 people with advanced kidney cancer that has spread. The goal is to see which combination works best at shrinking tumors. Participants will receive either a new two-drug or three-drug combo, or the current standard treatmen…
Matched conditions: METASTATIC RENAL CELL CARCINOMA (MRCC)
Phase: PHASE2 • Sponsor: Brian Rini • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New triple therapy aims to stop kidney cancer from spreading further
Disease control Recruiting nowThis study tests whether adding a drug that wakes up the immune system (IMSA101) and precise radiation (PULSAR) to standard immunotherapy can control metastatic kidney cancer that has started to grow in a few spots. About 15 adults with clear cell kidney cancer that has spread an…
Matched conditions: METASTATIC RENAL CELL CARCINOMA (MRCC)
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Global data dive: how immunotherapy fights advanced kidney cancer
Knowledge-focused Recruiting nowThis study looks back at medical records from 1220 people with advanced kidney cancer who received immunotherapy combinations as their first treatment. The goal is to learn how well these treatments work and how they affect different groups, like older patients or those with canc…
Matched conditions: METASTATIC RENAL CELL CARCINOMA (MRCC)
Sponsor: Hospital of Macerata • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC